CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

Overview of attention for article published in Breast Cancer Research, January 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 4 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 95 Mendeley

Summary Patents Wikipedia

So far, Altmetric has seen 4 patents that reference this research output.

EARLY-STAGE ALZHEIMER'S DISEASE AUTOANTIBODY BIOMARKERS, TARGET ANTIGENS AND DIAGNOSTIC…

Application EP-3978930-A1

European Patent Office

Tissue protective erythropoietin receptor (NEPOR) and methods of use

Application US-8357501-B2

United States of America

NOVEL CURCUMIN-ANTIBODY CONJUGATES AS ANTI-CANCER AGENTS

Application WO-2011068894-A3

World Intellectual Property Organisation (WIPO)

NOVEL CURCUMIN-ANTIBODY CONJUGATES AS ANTI-CANCER AGENTS

Application WO-2011068894-A2

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.